Effects of cyclosporine on cytokines and cytokine receptors in psoriasis
- 31 December 1995
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 33 (6), 947-953
- https://doi.org/10.1016/0190-9622(95)90285-6
Abstract
Oral cyclosporine is effective in the treatment of recalcitrant psoriasis. However, the precise mechanism(s) are not fully understood. A possible mode of action may be via down-modulation of proinflammatory cytokines that are increased in psoriatic lesions. This study was designed to monitor the effects of cyclosporine treatment on the expression of cytokines, cytokine receptors, and other markers of inflammation in psoriatic skin. Ten patients with recalcitrant psoriasis were treated with cyclosporine. The in vivo effects of cyclosporine on cytokines and their receptors were studied by the use of cryostat-cut sections and a panel of antibodies. The in vitro effects were studied with flow cytometry of epidermal cell suspensions prepared from psoriatic lesions and control skin. Clinical improvement was noted in all patients after 2 weeks of cyclosporine treatment. The expression of interleukin-1 beta, interleukin-8, CD25(IL-2R), CD36 and E-selectin were significantly decreased, whereas the number of tumor necrosis factor-receptor-positive epidermal cells was significantly increased in psoriatic lesions. Clinical improvement of psoriasis with cyclosporine treatment is accompanied by down modulation of proinflammatory epidermal cytokines and decreased dermal inflammation. Thus besides suppressing cytokine production by the inflammatory infiltrate, the beneficial effect of cyclosporine in psoriasis also depends on the inhibition of the epidermal cytokine network.Keywords
This publication has 20 references indexed in Scilit:
- Cyclosporin A inhibits keratinocyte cytokine gene expressionBritish Journal of Dermatology, 1994
- GRO-α mRNA Is Selectively Overexpressed in Psoriatic Epidermis and Is Reduced by Cyclosporin A In Vivo, But Not in Cultured KeratinocytesJournal of Investigative Dermatology, 1993
- The mechanisms of action of cyclosporin A in the treatment of psoriasisImmunology Today, 1993
- Studies of the Effect of Cyclosporine in Psoriasis In Vivo: Combined Effects on Activated T Lymphocytes and Epidermal Regenerative MaturationJournal of Investigative Dermatology, 1992
- Expression of Interferon-Gamma Receptors in Normal and Psoriatic SkinJournal of Investigative Dermatology, 1992
- Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin AClinical and Experimental Immunology, 1991
- Keratinocytes as initiators of inflammationThe Lancet, 1991
- Low-dose cyclosporin A in severe psoriasis. A double-blind studyBritish Journal of Dermatology, 1988
- Induction of Interleukin 2 Messenger RNA Inhibited by Cyclosporin AScience, 1984
- Gamma Interferon Synthesis by Human Thymocytes and T Lymphocytes Inhibited by Cyclosporin AScience, 1983